Tempus AI Stock Falls Despite Collaboration Announcement With Genialis
Tempus Ai Insider Sold Shares Worth $792,192, According to a Recent SEC Filing
Express News | Tempus Announces a Collaboration With Genialis to Develop Rna-Based Biomarker Algorithms
Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
The Zacks Analyst Blog Highlights Tempus AI, IRhythm Technologies and SOPHiA GENETICS
President Capital Initiates Tempus AI at Buy With $52 Price Target
Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion
S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead
Tempus AI Stock Plunges 28.9% in Three Months: What's Next?
Fund Managers See AI Delivering Big Gains for These 5 Stocks - Including Duolingo
Tempus AI Insider Sold Shares Worth $7,045,334, According to a Recent SEC Filing
Tempus AI's (TEM) AI-Powered Healthcare Revolution: What's Next?
Tempus AI(TEM.US) 10% Shareholder Sells US$7.05 Million in Common Stock
$Tempus AI(TEM.US)$ 10% Shareholder LEFKOFSKY ERIC P sold 187.66K shares of common stock on Dec 18, 2024 at an average price of $37.54 for a total value of $7.05 million.Source: Announcement What is
ARK Invest Shifts Focus: Adds Tempus AI, Reduces Tesla Holdings
Cathie Wood's ARK Buys Tempus AI Stock, Sells Tesla and Palantir
Tempus Signs Agreements For In-Network Provider Status With Blue Cross Blue Shield Of Illinois, Blue Shield Of California And Avalon Healthcare Solutions
New Strategy? Cathie Wood's ARK Purchases Shares in Futu, Significantly Increased Its Stake in AI Healthcare Company Tempus AI and Sold Off Shopify
Cathie Wood's ARK ETF announced the daily Trade details for Tuesday, December 17, 2024.
Tempus AI, Inc (TEM) Expands Partnership With Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma